Stay updated on TERN-201 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the TERN-201 Safety and Efficacy in NASH Clinical Trial page
- CheckyesterdayChange Detected- Deleted page metadata terms: 'Non-alcoholic fatty liver disease' and the related topics tag 'MedlinePlus Genetics' from the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedCore page content updated with a government-operating-status notice and a new MedlinePlus Genetics topic; page version bumped from v3.1.0 to v3.2.0.SummaryDifference6%

- Check30 days agoChange DetectedUpdate to version v3.1.0; removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, and a MedlinePlus Genetics topic) indicating content pruning alongside the core revision.SummaryDifference1%

- Check37 days agoChange Detected- Added MedlinePlus Genetics topic: Non-alcoholic fatty liver disease. - No deletions observed.SummaryDifference0.5%

- Check44 days agoChange DetectedThe page updates from Revision: v3.0.1 to v3.0.2, signaling a new release. Additionally, the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.3%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.3%

Stay in the know with updates to TERN-201 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.